Literature DB >> 22019047

Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells.

Ye Xu1, Huimei Yu, Hanjiao Qin, JinSong Kang, Chunyan Yu, Jiateng Zhong, Jing Su, HongYan Li, LianKun Sun.   

Abstract

The function of autophagy in cisplatin-treated cancer cells is not fully understood. Cisplatin treatment induced degradation of ubiquitinated proteins by autophagy, which reduced apoptosis induced by endoplasmic reticulum (ER) stress and downregulated the mitochondrial pathway of apoptosis. Inhibition of autophagy using 3-methyladenine (3-MA) or chloroquine (CQ) increased the levels of intracellular misfolded proteins, which enhanced cellular apoptosis. We found that tunicamycin, an ER stress inducer, augmented cisplatin cytotoxicity by upregulating ER stress-mediated apoptosis. Our data indicates that autophagy plays an important role in preventing cisplatin-induced apoptosis in HeLa cells, thus inhibition of autophagy may improve cisplatin chemotherapy.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22019047     DOI: 10.1016/j.canlet.2011.09.034

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  52 in total

1.  Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction.

Authors:  Zhenyu Liu; Aiping Shi; Dong Song; Bing Han; Zhiru Zhang; Le Ma; Dongxu Liu; Zhimin Fan
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Autophagy Inhibition Delays Early but Not Late-Stage Metastatic Disease.

Authors:  Rebecca A Barnard; Daniel P Regan; Ryan J Hansen; Paola Maycotte; Andrew Thorburn; Daniel L Gustafson
Journal:  J Pharmacol Exp Ther       Date:  2016-05-26       Impact factor: 4.030

3.  Enhancement of oxaliplatin-induced cell apoptosis and tumor suppression by 3-methyladenine in colon cancer.

Authors:  Shisheng Tan; Xingchen Peng; Wen Peng; Yinglan Zhao; Yuquan Wei
Journal:  Oncol Lett       Date:  2015-02-27       Impact factor: 2.967

4.  Role of Bcl-xL/Beclin-1 in interplay between apoptosis and autophagy in oxaliplatin and bortezomib-induced cell death.

Authors:  Seog-Young Kim; Xinxin Song; Lin Zhang; David L Bartlett; Yong J Lee
Journal:  Biochem Pharmacol       Date:  2014-01-31       Impact factor: 5.858

Review 5.  Targeting autophagy in cancer.

Authors:  Angelique V Onorati; Matheus Dyczynski; Rani Ojha; Ravi K Amaravadi
Journal:  Cancer       Date:  2018-04-19       Impact factor: 6.860

6.  Triptolide induces protective autophagy and apoptosis in human cervical cancer cells by downregulating Akt/mTOR activation.

Authors:  Guangyi Qin; Ping Li; Zhuowei Xue
Journal:  Oncol Lett       Date:  2018-07-04       Impact factor: 2.967

7.  In vitro chemoresponse to cisplatin and outcomes in cervical cancer.

Authors:  Perry W Grigsby; Israel Zighelboim; Matthew A Powell; David G Mutch; Julie K Schwarz
Journal:  Gynecol Oncol       Date:  2013-04-10       Impact factor: 5.482

Review 8.  Autophagy and cancer therapy.

Authors:  Andrew Thorburn; Douglas H Thamm; Daniel L Gustafson
Journal:  Mol Pharmacol       Date:  2014-02-26       Impact factor: 4.436

9.  Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma.

Authors:  Vito W Rebecca; Renato R Massaro; Inna V Fedorenko; Vernon K Sondak; Alexander R A Anderson; Eunjung Kim; Ravi K Amaravadi; Silvya S Maria-Engler; Jane L Messina; Geoffrey T Gibney; Ragini R Kudchadkar; Keiran S M Smalley
Journal:  Pigment Cell Melanoma Res       Date:  2014-02-21       Impact factor: 4.693

Review 10.  Regulation of autophagy by canonical and non-canonical ER stress responses.

Authors:  Monika Bhardwaj; Nektaria Maria Leli; Constantinos Koumenis; Ravi K Amaravadi
Journal:  Semin Cancer Biol       Date:  2019-12-12       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.